Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
I owned shares of (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar over 60% in roughly two years was fun. Seeing Pfizer's share price fall nearly 60% from its peak wasn't so fun.
Have I been tempted to sell during this major decline? Nope. Instead, I'm buying this beaten-down, high-yield dividend stock hand over fist.
It's understandable why Pfizer stock has fallen so much. The drugmaker has faced some big challenges and has more on the way.
Source Fool.com
Pfizer Inc. Aktie
27,73 €
-2,43 %
Die Community bevorzugt Pfizer Inc., mit deutlich mehr Buy- (29) als Sell-Einschätzungen (4).
Ein Kursziel von 41 € für Pfizer Inc. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 27.73 € bedeuten.
